Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β
Open Access
- 1 June 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 120 (7) , 1784-1800
- https://doi.org/10.1053/gast.2001.24832
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-β mediated fibrogenesis in vivoJournal of Hepatology, 1999
- Evaluation of Cationic Liposome Suitable for Gene Transfer into Pregnant AnimalsBiochemical and Biophysical Research Communications, 1999
- Protease inhibitors suppress TGF-β generation by hepatic stellate cellsJournal of Hepatology, 1998
- Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivoJournal of Hepatology, 1998
- Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activationJournal of Hepatology, 1997
- The Plasminogen–Activating System in Hepatic Stellate CellsHepatology, 1996
- Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellualr matrix-associated Arg-Gly-Asp epitopeJournal of Hepatology, 1996
- Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMPDigestive Diseases and Sciences, 1996
- Retinoic Acid-Stimulated Liver Stellate Cells Suppress the Production of Albumin from Parenchymal Cells via TGF-βBiochemical and Biophysical Research Communications, 1996
- Bovine urokinase-type plasminogen activator and its receptor: Cloning and induction by retinoic acidGene, 1993